
Molecure Investor Relations Material
Latest events

Q4 2024
Molecure
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Molecure S A
Access all reports
Molecure S.A. is a biotechnology company focused on the discovery and development of small molecule therapies for the treatment of inflammatory and fibrotic diseases, as well as cancer. The company leverages its proprietary research platforms to identify novel drug targets and advance its pipeline of investigational treatments. The company is headquartered in Warsaw, Poland, and its shares are listed on the WSE.
Key slides for Molecure S A


Investor Presentation
Molecure S A


Investor Presentation
Molecure S A
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
MOC
Country
🇵🇱 Poland